Table 2. Clinical variables for predicting EGFR activating mutations: Multiple logistic regression analysis results.
Variables | ORs | 95% CIs | P |
---|---|---|---|
Family history of lung cancer (yes v no) | 2.01 | 1.18–3.60 | 0.011 |
Age (increasing) | 1.00 | 0.98–1.01 | 0.947 |
Gender (female v male) | 2.07 | 1.20–3.61 | 0.011 |
Smoking habit (never v ever smoker) | 2.64 | 1.50–4.67 | 0.001 |
ECOG performance status (0–1 v 2–4) | 0.97 | 0.65–1.46 | 0.893 |
Body mass index (< 22.4 v ≥ 22.4) | 1.03 | 0.72–1.47 | 0.872 |
Histology (adenocarcinoma v non-adenocarcinoma) | 3.60 | 2.31–5.60 | < 0.001 |
Stages (I and II v III and IV) | 1.23 | 0.84–1.81 | 0.291 |
ECOG = Eastern Cooperative Oncology Group; Body mass index by 22.4 of median value